Pharma Equity Group A/S (PEG.CO)
DKK 0.18
(-2.17%)
DKK 0.18
(-2.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -16.62 Million | -2.87 Million | -2.08 Million | -9.9 Million | -274 Thousand | -1.57 Million |
| Net Income | -26.84 Million | 3.47 Million | 5.39 Million | -32.87 Million | -14.41 Million | -7.71 Million |
| Depreciation & Amortization | 480 Thousand | 539.00 | - | - | - | - |
| Deferred income taxes | - | -756.00 | - | - | - | - |
| Stock-based compensation | - | 217.00 | - | - | - | - |
| Change in working capital | 3.39 Million | 1.93 Million | -30 Thousand | -901 Thousand | 1.42 Million | 219 Thousand |
| Other non-cash items | 6.34 Million | -8.28 Million | -7.45 Million | 23.87 Million | 12.71 Million | 5.91 Million |
| Investing Cash Flow | -73 Thousand | - | - | - | 1.65 Million | - |
| Investments in PPE | -73 Thousand | - | - | - | -2.05 Million | - |
| Acquisitions | - | - | - | - | 1.65 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | 2.05 Million | - |
| Financing Cash Flow | 17.06 Million | 3.05 Million | 2.08 Million | 9.9 Million | -1.37 Million | 1.57 Million |
| Debt repayment | -4.32 Million | -3.05 Million | -500 Thousand | -8.85 Million | -530 Thousand | -1.38 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 12.19 Million | - | - | - | - | 194 Thousand |
| Other Financing Activities | 9.19 Million | 6.11 Million | 2.58 Million | 18.76 Million | -846 Thousand | 2.76 Million |
| Accounts receivables | -1.35 Million | 160.00 | - | - | - | - |
| Accounts payables | 2.02 Million | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | 2.72 Million | 1.92 Million | - | - | - | - |
| Cash at beginning of period | 2.83 Million | - | - | 1000.00 | 1000.00 | 3000.00 |
| Cash at end of period | 4.23 Million | 182 Thousand | - | 1000.00 | 1000.00 | 1000.00 |
| Capital Expenditure | -73 Thousand | - | - | - | -2.05 Million | - |
| Effect of forex changes on cash | 1.03 Million | - | - | - | - | - |
| Net cash flow / Change in cash | 1.4 Million | 182 Thousand | - | - | - | -2000.00 |
| Free Cash Flow | -16.69 Million | -2.87 Million | -2.08 Million | -9.9 Million | -2.32 Million | -1.57 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -5.86 Million | -7.17 Million | -26.84 Million | -13.79 Million | -4.62 Million | -5.01 Million |
| Depreciation & Amortization | 124 Thousand | 124 Thousand | 480 Thousand | -304 Thousand | 261 Thousand | 261 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 1.23 Million | -275 Thousand | 3.39 Million | 2 Million | 3.04 Million | -884 Thousand |
| Other non-cash items | 10 Thousand | -186 Thousand | 6.34 Million | 8.06 Million | -1.34 Million | -369 Thousand |
| Investing Cash Flow | - | - | -73 Thousand | - | - | - |
| Investments in PPE | - | - | -73 Thousand | - | - | - |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 2.53 Million | 5.79 Million | 17.06 Million | 6.79 Million | 634 Thousand | -2.55 Million |
| Debt repayment | -1.69 Million | -8.93 Million | -4.32 Million | -739 Thousand | -3.66 Million | -5000.00 |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | -1.1 Million | -3.08 Million | 12.19 Million | -3.85 Million | - | - |
| Other Financing Activities | 1.94 Million | -1000.00 | 9.19 Million | 7.53 Million | 4.3 Million | -2.55 Million |
| Accounts receivables | 538 Thousand | 1.67 Million | -1.35 Million | -1.7 Million | 1.59 Million | -1.2 Million |
| Accounts payables | 332 Thousand | -1.74 Million | 2.02 Million | 2.87 Million | 169 Thousand | -235 Thousand |
| Inventory | - | - | - | 5000.00 | - | - |
| Other working capital | 364 Thousand | -202 Thousand | 2.72 Million | 826 Thousand | 1.27 Million | 560 Thousand |
| Cash at beginning of period | 2.19 Million | 4.23 Million | 2.83 Million | 1.47 Million | 3.51 Million | 12.07 Million |
| Cash at end of period | 863 Thousand | 2.19 Million | 4.23 Million | 4.23 Million | 1.47 Million | 3.51 Million |
| Capital Expenditure | - | - | -73 Thousand | - | - | - |
| Effect of forex changes on cash | - | - | 1.03 Million | - | - | - |
| Net cash flow / Change in cash | -1.33 Million | -2.03 Million | 1.4 Million | 2.75 Million | -2.03 Million | -8.56 Million |
| Free Cash Flow | -3.87 Million | -7.82 Million | -16.69 Million | -4.03 Million | -2.67 Million | -6 Million |
VNPKF
CREATIVE
ARBEW
IVQ
MAIDEN
OMTK